Endometrial Hyperplasia and Endometrial Adenocarcinoma

The endometrium is one of the most sensitive target tissues responding to hormonal influences. It is capable of undergoing profound structural changes with an astonishing promptness, under the stimulation of sex hormones. These changes are manifested by the changes taking place with the menstrual cycle during the reproductive years, when the morphology of the endometrial tissue has different characteristics every day. Estrogens stimulate proliferation within the endometrial glands and stroma. The response to ovulation and subsequent secretion of progesterone is a dramatic arrest of any proliferative activity in the endometrial glands and a complex process of secretion, with maturation of the stroma and development of blood vessels, aiming to prepare the endometrium to be the host tissue for a possible implanting conceptus. Preview Unable to display preview. Download preview PDF. Similar content being viewed by others

Gurpide E, Tseng L, Gusberg SB: Estrogen metabolism in normal and neoplastic endometrium. Am J Obstet Gynecol 1977;129:809–816. Gorsky J, Stormshak F, Harris J, et al: Hormone regulation of growth: stimulatory and inhibitory influence of estrogens on DNA synthesis. J Toxicol Environ Health 1977;3:271–272. Muechler EK, Flickinger GL, Mangan CE, et al: Estradiol binding by human endometrial tissue. Gynecol Oncol 1975;3:244. Fechner RE, Kaufman RH: Endometrial adenocarcinoma in Stein-Leventhal syndrome. Cancer 1974;34:444–452. Chanlian DL, Taylor HB: Endometrial hyperplasia in young women. Obstet Gynecol 1970;36:659–666. Jackson RL, Dockerty MB: The Stein-Leventhal syndrome. Analysis of 43 cases with special references to association with endometrial adenocarcinoma. Am J Obstet Gynecol 1957;73:161–173. Louka MH, Ross RD, Lee JH, et al: Endometrial carcinoma in Turner’s syndrome. Gynecol Oncol 1978;6:294. Hulka BS, Kaufman DG, Fowler WC, et al: Predominance of early endometrial cancers after long term estrogen use. JAMA 1989;244:2419–2422. Ferenczy A: Cytodynamics of endometrial hyperplasia and neoplasia. Part II: In vitro DNA histo-auto-radiography. Hum Pathol 1983;14:77–82. Papadaki L, Beilby JOW, Chowaniec J, et al: Hormone replacement therapy in the menopause; a suitable animal model. J Endocrinol 1979;83:67–77. Gusberg SB: Precursors of corpus carcinoma: estrogens and adenomatous hyperplasia. Am J Obstet Gynecol 1947;54:905–927. Silverberg SG: Hyperplasia and carcinoma of the endometrium. Semin Diagn Pathol 1988;5:135–153. Kurman RJ, Norris HF: Endometrial hyperplasia and metaplasia, in Kurman RJ (ed): Blaustein’s Pathology of the Female Genital Tract, ed. 3. New York, Springer-Verlag, 1987, pp 322–337. Sachs H, Wambach EV, Würthner K: DNA content of normal, hyperplastic and malignant endometrium determined cytophotometrically. Arch Gynaekol 1974;217:349–365. Dallenbach-Hellweg G: Foam cells and estrogen activity of the human endometrium. Arch Gynaek 1974;217:335–341. Fechner RE: Ultrastructure of endometrial foam cells. Am J Clin Pathol 1979;72:628–633. Kurman RJ, Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547–2559. Fenoglio CM, Crum CP, Ferenczy A: Endometrial hyperplasia and carcinoma: are ultrastructural, biochemical and immunocytochemical studies useful in distinguishing between them? Pathol Res Pract 1982;174:257–284. Disaia PJ, Creasman WT: Adenocarcinoma of the uterus, in Clinical Gynecologic Oncology, ed 3. St. Louis: CV Mosby Co, 1989, pp 161–162. Disaia PJ, Creasman WT, Boronow MD, et al: Risk factors and recurrent patterns in stage I endometrial cancer. Am J Obstet Gynecol 1985;151:1009–1015. Mahboudi E, Eyler N, Wynder EL: Epidemiology of cancer of the endometrium. Clin Obstet Gynecol 1982;25:5–17. Beckner ME, Mori T, Silverberg SG: Endometrial carcinoma: non-tumor factors in prognosis. Int J Gynecol Pathol 1980;4:131–145. Christopherson WM, Connelly PJ, Alberhasky RC, et al: Carcinoma of the endometrium V. An analysis of prognosticates in patients with favorable subtypes and stage I disease. Cancer 1983;51:1705–1709. Deligdisch L, Cohen CJ: Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 1985;56:1452–1455. Gusberg SB: Current concepts in cancer. The changing nature of endometrial cancer. N Engl J Med 1980;302:719–731. Kurman RJ, Norris HJ: Endometrial carcinoma, in Kurman RJ (ed): Blaustein’s Pathology of the Female Genital Tract, ed 3. New York, Springer-Verlag 1987, pp 338–372. Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10–17. Silverberg SG, Sasano N, Yajima A: Endometrial adenocarcinoma in Miyagi Prefecture, Japan: Histopathologic analysis of a cancer-based series and comparison with cases in American women. Cancer 1982;49:1504–1510. Creasman WT, Soper JT, McCarty KS Jr, et al: Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma. Am J Obstet Gynecol 1985;151:922–932. Deligdisch L, Holinka CF: Progesterone receptors in two groups of endometrial adenocarcinoma. Cancer 1986;57:1385–1388. Deligdisch L, Holinka CF: Endometrial carcinoma: two diseases? Cancer Detection Prevent 1987;10:237–246. Holinka CF, Deligdisch L, Gurpide E: Histologic evaluation of in vitro-responses of endometrial adenocarcinoma to progestins and their relation to progesterone receptor levels. Cancer Res 1984;44:293–296. Gray LA, Christopherson WM, Hoover RN: Estrogens and endometrial carcinoma. Obstet Gynecol 1977;49:385–389. Lucas WE, Yen SC: A study of endocrine and metabolic variables in postmenopausal women with endometrial carcinoma. Am J Obstet Gynecol 1979;134:180–186. Silverberg SG, Muller D, Faraci JA, et al: Endometrial adenocarcinoma: clinical pathologic comparison of cases in postmenopausal women receiving and not receiving estrogens. Cancer 1985;56:1452–1455. Smith M, McCartney AJ: Occult high risk endometrial cancer. Gynecol Oncol 1985;22:154–161. Hendrickson M, Ross J, Eifel P, et al: Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Gynecol Oncol 1982;13:373–392. Laughlan SC: The secondary Mullerian system. Obstet Gynecol Surv 1972;27:133–143. Eifel P, Hendrickson M, Ross J, et al: Simultaneous presentation of carcinoma involving the ovary and uterine corpus. Cancer 1982;50:163–170. Ng ABP, Reagan JW, Storaasli JP, et al: Mixed adenosquamous carcinoma of the endometrium. Am J Clin Pathol 1973;59:765–781. Zaino RJ, Kurman RJ: Squamous differentiation in carcinoma of the endometrium: a critical appraisal of adeno-acanthoma and adenosquamous carcinoma. Semin Diagn Pathol 1988;5:154–171. Dutra F: Intraglandular morules of the endometrium. Am J Clin Pathol 1959;31:60–65. Tang EY, Bonfiglio TA, Tanga K: Effect of estrogen and progesterone on the development of endometrial hyperplasia in the Fischer rat. Biol Reprod 1984;31:399–413. Kay S: Squamous cell carcinoma of the endometrium. Am J Clin Pathol 1974;61:264–269. Silverberg SG: Significance of squamous elements in carcinoma of the endometrium: a review. Prog Surg Pathol 1981;4:115–119. Ross J, Eifel PH, Cox RS, et al: Primary mucinous adenocarcinoma of the endometrium. A clinico-pathologic and histochemical study. Am J Surg Pathol 1983;7:715–729. Hendrickson M, Ross J, Eifel P, et al: Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma. Am J Surg Pathol 1982;6:93–108. Kuebler DL, Nikrui N, Bell DA: Cytologic features of endometrial papillary serous carcinoma. Acta Cytol 1989;33:120–126. Kurman RJ, Scully RE: Clear cell carcinoma of the endometrium. An analysis of 21 cases. Cancer 1976;37:872–882. Silverberg SG, De Georgil LS: Clear cell carcinoma of the endometrium: clinical pathologic and ultrastructural findings. Cancer 1973;31:1127–1140. Nilsson O: Electron microscopy of human endometrial carcinoma. Cancer Res 1962;22:491–494. Tobon H, Watkins GJ: Secretory adenocarcinoma of the endometrium. Int J Gynecol Pathol 1985;4:328–335. Bulletti C, Galassi A, Jassoni VM, et al: Basement membrane components in normal, hyperplastic and neoplstic endometrium. Cancer 1988;62:142–149. King A, Seraj IM, Wagner RJ: Stromal invasion in endometrial carcinoma. Am J Obstet Gynecol 1984;149:10–14. Deligdisch L: Morphologic correlates of host response in endometrial carcinoma. Am J Reprod Immunol 1982;2:54–57. Dewagne MP, Silverberg SG: Foam cells in endometrial carcinoma. A clinico-pathologic study. Gynecol Oncol 1982;13:67–75. Hernandez E, Woodruff JD: Endometrial adenocarcinoma arising in adenomyosis. Am J Obstet Gynecol 1980;138:827–832. Van Nagel J, Donaldson ES, Hanson MB, et al: The role of carcinoembryonic antigen in the management of patients with gynecologic cancer. Am J Diagn Gynecol Obstet 1979;1:103–107. Editor information Editors and Affiliations Rights and permissions Copyright information © 1991 Springer-Verlag New York Inc. About this chapter Cite this chapter Deligdisch, L. (1991). Endometrial Hyperplasia and Endometrial Adenocarcinoma. In: Altchek, A., Deligdisch, L. (eds) The Uterus. Clinical Perspectives in Obstetrics and Gynecology. Springer, New York, NY. https://doi.org/10.1007/978-1-4613-9086-2_7 Download citation DOI: https://doi.org/10.1007/978-1-4613-9086-2_7 Publisher Name: Springer, New York, NY Print ISBN: 978-1-4613-9088-6 Online ISBN: 978-1-4613-9086-2 eBook Packages: Springer Book Archive

- Endometrial Cancer - Endometrial Carcinoma - Endometrial Hyperplasia - Endometrial Adenocarcinoma - Endometrial Polyp These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.